ProxyMed Chief Executive Officer Announces Retirement; Company Chairman, Kevin McNamara, Named Interim CEO

ATLANTA--(BUSINESS WIRE)--Jan. 11, 2005--ProxyMed, Inc. (Nasdaq:PILL) (the "Company"), a leading provider of healthcare transaction processing and medical cost containment services, announced today that Chief Executive Officer Michael K. Hoover has decided to retire, effective January 31, 2005. The Company has named its Chairman of the Board, Kevin M. McNamara, as Interim Chief Executive Officer and has retained Russell Reynolds Associates, a leading national executive search firm, to evaluate internal and external candidates to replace Mr. Hoover.